•
BM
BMY
Bristol-Myers Squibb Co.
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
110.38B
Volume
15.83M
52W High
$63.33
52W Low
$42.52
Open
$54.10
Prev Close
$54.22
Day Range
53.55 - 54.62
About Bristol-Myers Squibb Co.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Latest News
The Best Stocks to Invest $1,000 in Right Now
The Motley Fool•12h ago
High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
GlobeNewswire Inc.•13h ago
Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative
Investing.com•14h ago
U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships
GlobeNewswire Inc.•19h ago
Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool
Benzinga•Yesterday
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire Inc.•Jan 14
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
GlobeNewswire Inc.•Jan 13
Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs
Benzinga•Jan 7